Mutations Flashcards
11q-
Neuroblastoma
ALK
Neuroblastoma
ALCL t(2;5)
Inflammatory myofibroblastic tumor
ATRX
Neuroblastoma
CTNNB1
T: WNT pathway in medulloblastoma
N: Hepatoblastoma
N: Hepatocellular carcinoma
B: Desmoid tumor
LOH 16q
Wilms tumor - worse outcome
LOH 1p
Wilms tumor (worse outcome) Neuroblastoma (ass’d w MYCN amplification)
PHOX2B
Neuroblastoma: loss of function germ line mutation
TERT
Neuroblastoma
Dyskeratosis congenita
ELA2
ELANE
Severe congenital neutropenia
Cyclic neutropenia
HAX1
Kostmann Syndrome
“Hax out neutrophils at birth and Hax out neurological function”
Ass’d w/ neurological dysfunction
Mitochondrial DNA mutations
Pearson syndrome
“Mama Pearson”
Neutropenia/Anemia + Pancreatic insufficiency
Vacuolization of erythroid and myeloid precursors + ring sideroblasts in BM
MPL
CAMT
SBDS
Schwachmann-Diamond Syndrome
13q-
13q deletion syndrome: severe DD, birth defects, predisposition to RB
ATM
Ataxia Telangiectasia Syndrome:
- Ataxia and chorea when young
- Telangiectasia later in life
- Immunodifiency and infections
- Risk of leukemia and lymphoma
- Sensitivity to ionizing radiation
PTCH1
Gorlin Syndrome
Medulloblastoma (SHH subtype)
PTPN11
Noonan Syndrome
RAS/MAPK pathway
Increased risk of JMML, Neuroblastoma, ERMS
RECQL4
Rothmund-Thomson Syndrome
Predisposition to osteosarcoma
RET2
MEN2
Increased risk of medullary thyroid carcinoma and pheochromocytoma
RUNX1
Familial platelet disorder with predisposition to AML
VHL
Von Hippel-Lindau Disease
CXCR4
WHIM Syndrome Warts Hypogammaglobulinemia Infections Myelokathexis (neutrophils are stuck in the marrow)
GATA2
MonoMAC syndrome:
Monocytopenia
B and NK cytopenia
Atypical mycobacterium infection
Familial AML
Emberger syndrome: lymphedema, warts, predisposition to AML/MDS
HPS2
Hermansky-Pudlack syndrome type 2 Albinism Neutropenia and immune deficiency Platelet defects (DENSE GRANULES) Propensity to develop HLH Pulmonary fibrosis
Platelet aggregometry: Impaired secondary wave w/ epi and ADP
LYST
Chediak Higashi:
Albinism w/ giant granules in myeloid cells
Platelet defects (DENSE GRANULES)
Propensity to develop HLH
RAB27A
Griscelli Syndrome type 2 Partial albinism (silver hair) Propensity to HLH
STAT3
Job’s syndrome = Hyper IgE syndrome
Immunodeficiency (neutrophil chemotaxis, T cell function)
High IgE
Eosinophilia
HLA-DR
Marker of immaturity Common in leukemias except: APML FAB M3 AMKL FAB M7 T-ALL
TDT
Lymphoid immaturity (B- and T-ALL)
CD10
B-ALL
Not in KMT2A-rearranged B-ALL
+ in 33% of T-ALL
CD15
Classical Hodgkin Lymphoma
+ CD15
+ CD30
- CD45
CD19
B cell marker
CD20
B cell marker
CD22
B-ALL
Only in mature B-cells, not ALL
CD30
Classical Hodgkin’s lymphoma
PMBL
ALCL
CD45
NLPHL
+ CD45
- CD15
- CD30
ALCL
+ ALK
+ CD30
+ CD45
CD79
B cell marker
CD3
T cell marker
CD4
T helper cell marker Binds to MHC class II expressed on antigen-presenting cells
CD5
T cell marker
CD7
T cell marker
CD8
Cytotoxic T cell marker
Binds to MHC class I expressed on all healthy cells as part of self-surveillance
CD13
Pan-myeloid marker
+ in AML
CD14
Monocytic marker
CD163
Rosai-Dorfman disease
CD1a
LCH marker
CD207
LCH marker
CD33
Pan myeloid marker
+ in AML
- in AMKL FAB M7
CD11b
Loss of CD11a/b in LAD type 1
Forms macrophage-1 antigen receptor, Mac-1, when bound to CD18
CD18
Loss of CD18 in LAD type 1
CD235A
Erythroid marker
+ in AML FAB M6
CD55
PNH
Mutations in PIGA -> deficiency of CD55/59
Allows C3 to activate the alternate pathway and mediate hemolysis
Pts also at risk for thrombosis
CD59
PNH
Mutations in PIGA -> deficiency of CD55/59
Pts at risk for thrombosis
CD41a
Platelet marker
+ in AMKL FAB M7
CD42
Platelet marker
+ in AMKL FAB M7
CD61
Platelet marker
+ in AMKL FAB M7
GPIb
Absent in BERNARD SOULIER Syndrome
Binds vWF
Pathologically higher affinity of GPIb in VWD type 2B
Platelet aggregometry: normal except for ristocetin
GPIIb/IIIa
Deficient in GLANZMAN’S THROMBASTHENIA
Platelet marker that binds to fibrin
Platelet aggregometry: all abnormal except for ristocetin
CD107a
Degranulation marker
Measures NK cell function
Useful in diagnosing HLH
CD56
Neuroblastoma marker
NK cell marker
CD99
Neuroblastoma
PNET
Desmin
RMS
Muscle Specific Actin
RMS
MyoD
RMS
Myogenin
RMS
Diffusely positive in ARMS
Patchy positive in ERMS
NSE
Neuroblastoma
Synaptophysin
Neuroblastoma
PNET
Vimentin
Ewing sarcoma
PNET
NF1 Related Tumors (6)
- Benign neurofibromas: cutaneous, subcutaneous, plexiform
- Low grade optic pathway gliomas
- ERMS (RAS pathway activation)
- JMML (RAS pathway activation)
- Malignant peripheral nerve sheath tumor (MPNST)
- Pheochromocytoma
NF2 Related Tumors (4)
- B/L vestibular schwannoma (acoustic neuroma)
- Meningioma
- Ependymoma
- Schwannoma
Congenital (juvenile) pernicious anemia
AR mutation in intrinsic factor gene
Problem with absorption of vitamin B12
Tx: IM B12
Imerslund-Grasbeck syndrome
AR mutation in AMN or CUBN
Problem with vitamin B12 and intrinsic factor complex absorption
Causes macrocytic anemia and neurologic symptoms early in infancy
Tx: IM B12
Transcobalamin II deficiency
Problem with vitamin B12 transport into the target cells
Serum vitamin B12 levels are normal because it is still absorbed and bound to transcobalamin I in the serum
Causes severe pancytopenia, diarrhea, and FTT
Endocrine complication of diffuse liver hemangioma
Hypothyroidism
Cancer from vinyl chloride exposure
Hepatic angiosarcoma
Next evaluation of an infant with > or = 5 cutaneous infantile hemangiomas
Liver ultrasound to look for liver hemangiomas
CGD ppx
Bactrim
Itraconazole
Patient with diabetes and fungal infections
Myeloperoxidase deficiency
Disorder associated with splenic rupture and miscarriages
Afibrinogenemia
Dysfibrinogenemia
Pathognomonic for osteosarcoma
Tumor osteoid
soft tissue sarcoma associated with immunosuppression, HIV, or RB1 deficient patients (in the uterus)
Leiomyosarcoma
Contact factors
Factor XII
Prekallikrein
HMWK
Deficiencies cause prolonged PTT without bleeding
Ovarian tumor with virilization
Sertoli-Leydig tumor: elevated levels of testosterone cause secondary amenorrhea and virilization
Ovarian tumor with precocious puberty or secondary amenorrhea
Juvenile granulosa cell tumor: elevated levels of estrogen cause precocious puberty (if prepubertal) or secondary amenorrhea (if postpubertal)
What do sex cord stromal tumors produce?
Inhibin
Can be used to diagnose and followup
Pure fetal histology hepatoblastoma tx
Resection and observation, no chemo
Liver tumors with low AFP
Small cell undifferentiated hepatoblastoma: often with loss of INI1 and rhabdoid-like
Fibrolamellar variant of HCC
GCT with high AFP
Yolk sac tumor
GCT with high b-HCG
Choriocarconoma
Diencephalic syndrome
Thalamic and hypothalamic low grade glioma
FTT, emaciation despite regular intake
Parinaud syndrome
Tumors of the pineal region
Upgaze paralysis, convergence retraction nystagmus, pupillary dilation with light-near dissociation
Rosenthal fibers
Pilocytic astrocytoma
Perivascular pseudorosette
Ependymoma
t(12;21)
B-ALL
ETV6(12) and RUNX1(21) translocation
TEL-AML1
Good prognosis
t(9;22)
B-ALL and CML
BCR(22) and ABL1(9) translocation
Bad outcomes for B-ALL. Better with TKIs
11q23 fusions
Infantile ALL and AML commonly M4/M5: KMT2A (11, aka MLL)
t(8;14)
Burkett’s lymphoma/leukemia: cMYC and IGH translocation
t(8;21)
AML M2: RUNX1 (21) and RUNX1T1 (8) translocation (aka, AML1-ETO_
Core binding factor related AML
Most commonly in FAB M2 (AML with maturation)
Inv(16)
AML M4eo: inversion leads to fusion of CBFB (16) and MYH11 (16)
Core binding factor related AML
Most commonly in FAB M4eo AML
t(15;17)
AML M3: PML (15) and RARa (17) translocation
t(1;13)
ARMS
PAX7-FOXO1
t(2;13)
ARMS: PAX3-FOXO1
t(11;22)
Ewing sarcoma: EWS (22) and FLI1 (11)
GATA1
Down Syndrome related AMKL and TAM
Arises in the fetal liver and is present in both AMKL and TAM
Second hit mutation required to progress from TAM to AMKL
NF1 NRAS KRAS PTPN11 CBL
JMML
Activating germline or somatic mutation in RAS pathway
Possible spontaneous resolution with Noonan’s syndrome (PTPN11)
BRAF V600E
LCH
Some pilocytic astrocytomas
Papillary craniopharyngioma
H3K27M
DIPG
Horrible prognosis. Horrible mutation to memorize
MYCN
Neuroblastoma
High risk feature
SMARCB1
Rhabdoid tumors (ATRT) Schwannomatosis
WT1
Sporadic Wilms tumor
WAGR
Denys-Drash Syndrome
FAS
FASL
CASP10
ALPS
What is needed to diagnose ALPS?
> 6months of lymphadenopathy or splenomegaly
Increased DN-T cells
One primary accessory criterion: defective lymphocyte apoptosis or characteristic mutation
What is needed to make a probable ALPS diagnosis?
> 6months of lymphadenopathy or splenomegaly
Increased DN-T cells
No primary but one secondary criterion:
1. Elevated plasma levels of FASL or IL-10 or IL-18 or Vitamin B12 levels
2. Consistent immunohistology
3. Autoimmune cytopenias AND elevated IgG
4. Family history of lymphoproliferation
gp47 phox
CGD: AR (25%)
Defects in phagocyte NADPH oxidase leading to immunodeficiency
gp91 phox
CGD: X-linked (70%)
Defects in phagocyte NADPH oxidase leading to immunodeficiency
What are the familial HLH mutations?
PRF1 UNC13D STX11 RAB27A SH2D1A XIAP
“The family with HLH carried their stuff in a trunk. They PERForated it with holes and put STX (sticks) through it to make the trUNC easier to carry.”
PIGA
PNH
Somatic mutations -> deficiency of CD55/59
No CD55/59 on RBCs allows complement (C3) to activate the alternative pathway and mediate hemolysis.
Increased risk of thrombosis
11p15
BWS
DICER1
DICER Syndrome Increased risk of several cancers: PPB Thyroid/multinodular goiter Cystic nephromas Botryoid RMS Serotoli-Leydig sex cord stromal tumors
RB1
Inherited retinoblastoma Associated with other cancers: - Osteosarcoma - Pineoblastoma (trilateral RB) - Soft tissue sarcomas (Leiomyosarcoma > fibrosarcoma)
TP53
Li-Fraumeni Syndrome Increased cancer risk - Sarcomas - Malignant glioma - Low-hypodiploid ALL - Choroid plexus carcinoma - Adrenocortical carcinoma
TSC1/TSC2
Tuberous Sclerosis Clinical: - Hypopigmented lesions (ash leaf) - Facial angiofibromas - Benign hamartomas (tubers) - Subependymal giant cell astrocytoma (SEGA): MTOR inhibitors - Renal cell carcinoma
del(5q)
MDS/AML
Therapy related AML after exposure to alkylating agents or radiation
del(7q)
MDS/AML
Therapy related AML after exposure to alkylating agents or radiation
del(X)
del(Y)
Ph-like ALL: creates a P2RY8-CRLF2 fusion
More common in Hispanic adolescents
iAMP(21)
B-ALL
Amplification of chromosome 21 leading to >/= 3 copies of RUNX1
Worse outcome
t(1;19)
B-ALL
TCF3 (19) and PBX1 (1) translocation (E2A-PBX1)
t(1;22)
AMKL
RBM15 (1, aka OTT) and MKL1 (22) translocation
t(10;11)
AML
KMT2A (11q23) and AF10 (10)
Mostly in AML FAB M4/M5
t(11;14)
T-ALL
TCRA/TCRD (14) and LMO2 (11) translocation
t(11;19)
ALL/AML
KMT2A (11q23) and ENL (19) translocation
t(2;5)
ALCL
ALK (2) and NPM1 (5) translocation
t(2;8)
Burkitt’s lymphoma/leukemia
cMYC (8) and kappa light chain promoter (2) alternate translocation
t(4;11)
Infantile ALL
KMT2A (11q23) and AF4 (4) translocation
t(8;22)
Burkitt’s lymphoma/leukemia
cMYC (8) and lambda light chain promoter (22) alternate translocation
t(9;11)
Infantile ALL
KMT2A (11a23) and AF9 (9)
i(12p)
Germ cell tumors: gain of short arm of chromosome 12
RELA fusion
Subtype of supratentorial ependymoma
Poor prognosis
Supernumerary ring chromosome (12q13-15)
Parosteal osteosarcoma: low grade, treated with resection alone
Burkitt Lymphoma Markers
Burkitt Lymphoma: Mature B cell NHL MYC translocations Surface IgM and Ig light chains B cell markers: CD19, CD20, CD22, CD79a Germinal Center markers: CD10, BCL6 HLA-DR, CD43 EBV associated: CD21
Burkitt Lymphoma Markers
Burkitt Lymphoma: Mature B cell NHL MYC translocations Surface IgM and Ig light chains B cell markers: CD19, CD20, CD22, CD79a Germinal Center markers: CD10, BCL6 HLA-DR, CD43 EBV associated: CD21
DLBL markers
Mature B Cell Hodgkin Lymphoma CD19 CD20 CD22 CD79a PAX5 CD10 BCL6
DLBL markers
Mature B Cell Hodgkin Lymphoma CD19 CD20 CD22 CD79a PAX5 CD10 BCL6
DLBL markers
Mature B Cell Non Hodgkin Lymphoma CD19 CD20 CD22 CD79a PAX5 CD10 BCL6
ALCL Markers
Mature T cell Non Hodgkin Lymphoma
NPM-ALK
CD30
CD45
ALCL Markers
Mature T cell Non Hodgkin Lymphoma
NPM-ALK
CD30
CD45
What is IL2RG associated with?
T-B+ SCID
Normal number of B cells but don’t function properly due to lack of antibody production by T helper cells.
What is JAK3 associated with?
T-B+ SCID
Normal number of B cells, but they don’t function properly due to lack of antibody production by T helper cells.
What is IL7R associated with?
T-B+ SCID
Low T cell number
Normal NK cells
Normal number of B cells but don’t function properly due to lack of antibody production by T helper cells.
What is AK2 associated with?
T-B- SCID
Also with NK cell deficiency
Severe neutropenia
Premature, SGA, sick
What is ADA deficiency associated with?
T-B- SCID
Toxic metabolites build up in T, B, and NK cells
What is RAG1/RAG2 mutation associated with?
T-B- SCID
This is needed for TCR and BCR recombination but not for NK cells.
What is DCLRE1C (Artemis) mutation associated with?
T-B- SCID
It is needed for DNA repair but not for NK cells
What does the dilute Russel viper venom time test for?
Lupus anticoagulant cause by an antiphospholipid antibody
Inhibitors are more common in which type of hemophilia?
Hemophilia A
What is the Steinherz-Beyer algorithm?
Evaluation of CNS (leukemia) disease in a traumatic lumbar puncture.
CSF WBC >/= 5 AND
CSF WBC/CSF RBC is >2x Blood WBC/Blood RBC = CNS3